We have observed
10 EP applications
Magda Anastassova Dineva
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after July 20, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Combination therapy with antibodies and anti-VEGF agents for the treatment of cancer
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT COMPLEMENT ACITIVATION
STABLE ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION
COMPOSITION AND METHOD FOR DIVERSIFICATION OF TARGET SEQUENCES
Stabilized p53 peptides and uses thereof
METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION
SYSTEMS AND METHODS FOR HIGH THROUGHPUT ANALYSIS OF CONFORMATION IN BIOLOGICAL ENTITIES